Skye Bioscience, Inc.

8-K Other events Jun 23, 2026 8-K Amended charter or bylaws; Shareholder vote results May 29, 2026 8-K Delisting notice or listing-rule failure May 15, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K/A Director or officer change Apr 6, 2026 8-K Director or officer change Apr 3, 2026 8-K Delisting notice or listing-rule failure Mar 19, 2026 8-K Results of operations (earnings release) Mar 10, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Director or officer change Feb 20, 2026 8-K Regulation FD disclosure; Other events Feb 2, 2026 8-K Entered a material agreement Dec 23, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Regulation FD disclosure Oct 6, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Changed accountants; Shareholder vote results Jun 11, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) Mar 20, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Director or officer change Feb 26, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change; Other events Oct 29, 2024 8-K Director or officer change; Shareholder vote results Oct 24, 2024 8-K Director or officer change; Regulation FD disclosure Sep 4, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Director or officer change; Regulation FD disclosure Jul 3, 2024 8-K Other events Jun 10, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Regulation FD disclosure Apr 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 8-K Entered a material agreement; Unregistered sale of equity Mar 13, 2024 8-K Director or officer change; Other events Mar 4, 2024 8-K Other events Feb 12, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 29, 2024 8-K Entered a material agreement; Terminated a material agreement Dec 5, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023